
<!DOCTYPE article
  PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Archiving and Interchange DTD with MathML3 v1.4 20241031//EN" "JATS-archivearticle1-4-mathml3.dtd">
<article article-type="research-article" xml:lang="en" dtd-version="1.4"><front><journal-meta><journal-id journal-id-type="nlm-ta">Afr J Paediatr Surg</journal-id><journal-id journal-id-type="iso-abbrev">Afr J Paediatr Surg</journal-id><journal-id journal-id-type="pmc-domain-id">3011</journal-id><journal-id journal-id-type="pmc-domain">ajps</journal-id><journal-id journal-id-type="nlm-id">101255062</journal-id><journal-id journal-id-type="publisher-id">AJPS</journal-id><journal-title-group><journal-title>African Journal of Paediatric Surgery: AJPS</journal-title></journal-title-group><issn pub-type="ppub">0189-6725</issn><issn pub-type="epub">0974-5998</issn><?publisher_abbrev medknow?><publisher><publisher-name>Wolters Kluwer -- Medknow Publications</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC6419554</article-id><article-id pub-id-type="pmcid-ver">PMC6419554.1</article-id><article-id pub-id-type="pmcaid">6419554</article-id><article-id pub-id-type="pmcaiid">6419554</article-id><article-id pub-id-type="pmid">30829301</article-id><article-id pub-id-type="doi">10.4103/ajps.AJPS_78_16</article-id><article-id pub-id-type="publisher-id">AJPS-15-5</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Original Article</subject></subj-group></article-categories><title-group><article-title>Indocyanine Green Clearance Test to Evaluate Liver Function in Rat Model of Extrahepatic Biliary Atresia</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Dutta</surname><given-names initials="HK">Hemonta Kr</given-names></name><xref ref-type="aff" rid="aff1"/><xref ref-type="corresp" rid="cor1"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Rao</surname><given-names initials="DN">D. N.</given-names></name><xref ref-type="aff" rid="aff2">1</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Gupta</surname><given-names initials="DK">D. K.</given-names></name><xref ref-type="aff" rid="aff3">2</xref></contrib></contrib-group><aff id="aff1">Department of Pediatric Surgery, Assam Medical College, Dibrugarh, Assam, India</aff><aff id="aff2"><label>1</label>Department of Biochemistry, AIIMS, New Delhi, India</aff><aff id="aff3"><label>2</label>Department of Pediatric Surgery, AIIMS, New Delhi, India</aff><author-notes><corresp id="cor1"><bold>Address for correspondence:</bold> Dr. Hemonta Kr Dutta, Department of Paediatric Surgery, Assam Medical College, Dibrugarh, Assam, India. E-mail: <email xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="hemontdut@gmail.com">hemontdut@gmail.com</email></corresp></author-notes><pub-date pub-type="ppub"><season>Jan-Mar</season><year>2018</year></pub-date><volume>15</volume><issue>1</issue><issue-id pub-id-type="pmc-issue-id">331071</issue-id><fpage>5</fpage><lpage>9</lpage><pub-history><event event-type="pmc-release"><date><day>01</day><month>01</month><year>2018</year></date></event><event event-type="pmc-live"><date><day>17</day><month>04</month><year>2019</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2019-04-18 00:20:41.137"><day>18</day><month>04</month><year>2019</year></date></event></pub-history><permissions><copyright-statement>Copyright: © 2019 African Journal of Paediatric Surgery</copyright-statement><copyright-year>2019</copyright-year><license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="http://creativecommons.org/licenses/by-nc-sa/4.0"><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/" specific-use="textmining" content-type="ccbyncsalicense">https://creativecommons.org/licenses/by-nc-sa/4.0/</ali:license_ref><license-p>This is an open access journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="AJPS-15-5.pdf"><?pdf-name AJPS-15-5.pdf?><?pdf-size 1616385?><?pdf-md5 f4ca0ef569958fda1bfefdfc5f921325?><?pdf-image-server-status NEVER_LOAD?><?pdf-cloudpmc-urn urn:app:153d/6419554/f4ca0ef56995/AJPS-15-5.pdf?></self-uri><abstract><sec id="st1"><title>Background:</title><p>Indocyanine green clearance test (ICG-K) has been shown as a sensitive marker of liver function in patients with cirrhosis. However, its role in the assessment of liver function in children with biliary atresia is not well established. The present study was undertaken to evaluate the ICG-K in an experimental model of cholangitis and partial biliary obstruction.</p></sec><sec id="st2"><title>Materials and Methods:</title><p>Thirty albino rats were divided into 3 groups of 10 each. After exploration under anesthesia, a vial of OK-432 diluted in 0.2 ml of normal saline was injected into the common bile duct (CBD) in rats of Groups B and C. In the control Group A, only saline was injected. Re-exploration was done at 3 weeks in Groups A and B and at 6 weeks in Group C, and freshly prepared ICG was injected into the inferior vena cava. Blood samples were collected at periodic intervals, optical density of the serum was measured, and half-life of ICG and fractional clearance (K) were calculated. Blood and tissue samples were obtained for biochemical tests and histological examination.</p></sec><sec id="st3"><title>Results:</title><p>The histological changes in CBD and liver were maximum in Group B; this correlated well with the K-value in this group, which was significantly delayed. In Group C, clearance was delayed than the control group with histological changes ranged from mild to moderate inflammation. The control group had normal histology of liver and CBD, and only four rats showed mild portal inflammation.</p></sec><sec id="st4"><title>Conclusion:</title><p>ICG clearance rate is a reliable marker of liver function and can be utilized for evaluation of liver function in postoperative extrahepatic biliary atresia patients.</p></sec></abstract><kwd-group><title>Keywords:</title><kwd>Biliary atresia</kwd><kwd>indocyanine green clearance test</kwd><kwd>liver function</kwd><kwd>OK-432</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-license-ref</meta-name><meta-value>CC BY-NC-SA</meta-value></custom-meta></custom-meta-group></article-meta></front><body><sec sec-type="intro" id="sec1-1"><title>I<sc>NTRODUCTION</sc></title><p>Liver functions in extrahepatic biliary obstruction have been customarily evaluated by the estimation of serum bilirubin and liver enzymes. However, these tests are not always reliable. Indocyanine green (ICG) is a tricarboxylic acid compound, and following intravenous injection, it is excreted solely by the liver alongside bile. Earlier studies have shown that the ability of the hepatocytes to take up ICG becomes rate limiting at very high concentrations, and ICG clearance (ICG-K) under these circumstances represents a sensitive measure of liver cell function.[<xref rid="ref1" ref-type="bibr">1</xref>] The present study was conducted to evaluate the fractional clearance of ICG in an experimental rat model of cholangitis with partial biliary obstruction.</p></sec><sec sec-type="materials|methods" id="sec1-2"><title>M<sc>ATERIALS AND</sc> M<sc>ETHODS</sc></title><p>The study was approved by the institutional ethics committee. A total of 30 albino rats each weighing from 80 to 100 g were selected and randomly divided into 3 groups of 10 each. After inducing anesthesia by intraperitoneal ketamine injection (@ 50mg/kg), a midline laparotomy was performed. Common bile duct (CBD) was identified and 0.2 ml of diluted sclerosant (OK-432 in normal saline) was injected into the CBD with a tuberculin syringe in rats of Groups B and C [Figures <xref ref-type="fig" rid="F1">1</xref> and <xref ref-type="fig" rid="F2">2</xref>]. Group A was taken as control and only normal saline was injected in these rats. The abdomen was closed. Each group of animals was housed separately in suitable environmental conditions (12 h daylight at 22°C temperature) with food and water “<italic toggle="yes">ad libitum</italic>.” All the rats underwent re-explorations at 3, 3, and 6 weeks in Groups A, B, and C, respectively. Freshly prepared ICG (1 mg in 500 μl of 0.1 M phosphate-buffered saline, pH 7.4 of distilled water) was injected into the infrahepatic vena cava at the dose of 1 mg/kg body weight [<xref ref-type="fig" rid="F3">Figure 3</xref>]. Blood samples (0.5 ml) were taken from abdominal aorta at 0,1,3,5 and 10 min [<xref ref-type="fig" rid="F4">Figure 4</xref>]. Serum was separated and the optical density was measured in a spectrophotometer (SHIMADZU UV-160A) at wavelengths of 815 nm. A standard curve was obtained by adding freshly prepared ICG to rat sera with a concentration range of 2–12 μg of ICG [<xref ref-type="fig" rid="C1">Chart 1</xref>]. Optical density was measured at wavelengths of 815 nm and the values were plotted on a graph. The amount of ICG in the test samples was calculated from the standard curve; half-life of ICG was calculated, and then, the fractional clearance (k) of ICG was determined after plotting these values on a graph. Blood samples were also taken for the estimation of serum bilirubin and liver enzymes. The specimens of the liver, bile duct, and duodenum were harvested in 10% formalin. Sections of the liver and CBD were embedded in paraffin wax, sectioned (5 μm), and stained with hematoxylin and eosin for evaluation. The parameters evaluated were as follows: the presence of inflammatory cells (cholangitis), portal fibrosis, and ductal proliferation.</p><fig id="F1" position="float" orientation="portrait"><label>Figure 1</label><caption><p>Photograph showing the liver, common bile duct, and duodenal loop; pointer showing the common bile duct</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="AJPS-15-5-g001.jpg"><?image-name AJPS-15-5-g001.jpg?><?image-size 51781?><?image-md5 e5e0d07424ba4e27495e9c660e5e122d?><?image-image-server-status LOAD_COMPLETED?><?image-original-height 529?><?image-original-width 809?><?image-scaled-height 352?><?image-scaled-width 539?><?image-cloudpmc-urn urn:cdn:blobs/153d/6419554/e5e0d07424ba/AJPS-15-5-g001.jpg?><?thumb-name AJPS-15-5-g001.gif?><?thumb-size 9454?><?thumb-md5 f287c614d155148b175d2150e863a0c8?><?thumb-image-server-status NEVER_LOAD?><?thumb-scaled-height 80?><?thumb-scaled-width 122?><?thumb-cloudpmc-urn urn:cdn:blobs/153d/6419554/f287c614d155/AJPS-15-5-g001.gif?></graphic></fig><fig id="F2" position="float" orientation="portrait"><label>Figure 2</label><caption><p>OK-432 being injected into the common bile duct</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="AJPS-15-5-g002.jpg"><?image-name AJPS-15-5-g002.jpg?><?image-size 54376?><?image-md5 78efb013bbcfffba086e678f6129511f?><?image-image-server-status LOAD_COMPLETED?><?image-original-height 527?><?image-original-width 809?><?image-scaled-height 351?><?image-scaled-width 539?><?image-cloudpmc-urn urn:cdn:blobs/153d/6419554/78efb013bbcf/AJPS-15-5-g002.jpg?><?thumb-name AJPS-15-5-g002.gif?><?thumb-size 9536?><?thumb-md5 bd5b0a959d0655bd49c223c4b4354ccf?><?thumb-image-server-status NEVER_LOAD?><?thumb-scaled-height 79?><?thumb-scaled-width 122?><?thumb-cloudpmc-urn urn:cdn:blobs/153d/6419554/bd5b0a959d06/AJPS-15-5-g002.gif?></graphic></fig><fig id="F3" position="float" orientation="portrait"><label>Figure 3</label><caption><p>Indocyanine green being injected into the inferior vena cava</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="AJPS-15-5-g003.jpg"><?image-name AJPS-15-5-g003.jpg?><?image-size 52845?><?image-md5 dbe84a9adcc57d7aa10c8da7f591c9b1?><?image-image-server-status LOAD_COMPLETED?><?image-original-height 523?><?image-original-width 809?><?image-scaled-height 348?><?image-scaled-width 539?><?image-cloudpmc-urn urn:cdn:blobs/153d/6419554/dbe84a9adcc5/AJPS-15-5-g003.jpg?><?thumb-name AJPS-15-5-g003.gif?><?thumb-size 9804?><?thumb-md5 96fa7c89bf69dd9b677894f604003a83?><?thumb-image-server-status NEVER_LOAD?><?thumb-scaled-height 80?><?thumb-scaled-width 123?><?thumb-cloudpmc-urn urn:cdn:blobs/153d/6419554/96fa7c89bf69/AJPS-15-5-g003.gif?></graphic></fig><fig id="F4" position="float" orientation="portrait"><label>Figure 4</label><caption><p>Blood sample collected from the abdominal aorta</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="AJPS-15-5-g004.jpg"><?image-name AJPS-15-5-g004.jpg?><?image-size 55353?><?image-md5 7a2c74a270dab71c4215d12e4d292ed8?><?image-image-server-status LOAD_COMPLETED?><?image-original-height 519?><?image-original-width 809?><?image-scaled-height 346?><?image-scaled-width 539?><?image-cloudpmc-urn urn:cdn:blobs/153d/6419554/7a2c74a270da/AJPS-15-5-g004.jpg?><?thumb-name AJPS-15-5-g004.gif?><?thumb-size 9543?><?thumb-md5 b92a8df202091480c2e3c452d4a6067b?><?thumb-image-server-status NEVER_LOAD?><?thumb-scaled-height 80?><?thumb-scaled-width 124?><?thumb-cloudpmc-urn urn:cdn:blobs/153d/6419554/b92a8df20209/AJPS-15-5-g004.gif?></graphic></fig><fig id="C1" position="float" orientation="portrait"><label>Chart 1</label><caption><p>Standard curve showing optical density of ICG in isolated rat sera with concentration range from2 to 12 μg of indocyanine green</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="AJPS-15-5-g005.jpg"><?image-name AJPS-15-5-g005.jpg?><?image-size 16328?><?image-md5 fd363eb434698dc716f48cb6afa6ed77?><?image-image-server-status NEVER_LOAD?><?image-original-height 207?><?image-original-width 325?><?image-scaled-height 207?><?image-scaled-width 325?><?image-cloudpmc-urn urn:cdn:blobs/153d/6419554/fd363eb43469/AJPS-15-5-g005.jpg?><?thumb-name AJPS-15-5-g005.gif?><?thumb-size 3380?><?thumb-md5 198c25d51de9beb36ac131e427842078?><?thumb-image-server-status NEVER_LOAD?><?thumb-scaled-height 80?><?thumb-scaled-width 125?><?thumb-cloudpmc-urn urn:cdn:blobs/153d/6419554/198c25d51de9/AJPS-15-5-g005.gif?></graphic></fig></sec><sec sec-type="results" id="sec1-3"><title>R<sc>ESULTS</sc></title><p>Of total 30 rats, four rats died due to unrelated causes and eight rats were taken from each group for study. Optical density of ICG in each serum sample was noted down, and serum concentration of the dye in μg was obtained from the standard curve [<xref ref-type="fig" rid="C1">Chart 1</xref>]. In control group (Group A), clearance of the dye occurred in nearly exponential manner for 3–5 min, following which a deceleration of clearance occurred in all cases. Clearance of ICG was suppressed in rats of Groups B and C. Values were plotted on a graph with zero-time concentration taken as unity. The t/2 was calculated from the graph. The clearance curve of the groups was shown in the same plot for comparison [<xref ref-type="fig" rid="C2">Chart 2</xref>]. The rats in the control group had a mean K-value of 0.239 ± 0.013; in Group B, it was 0.079 ± 0.009, and in Group C, the K-value was of 0.112 ± 0.005. Four of the eight rats in Group A had normal histology of the liver and porta. In the other four rats, there was mild portal inflammation. In Group B, four rats had mild-to-moderate inflammation and the other four had moderate-to-severe inflammatory changes in the portal structures. In Group C, four rats had mild and the other four had moderate-to-severe inflammatory changes. The degree of sinusoidal and portal inflammation was significantly higher in Groups B and C in comparison to Group A, where changes were mild (<italic toggle="yes">P</italic> &lt; 0.05) [<xref rid="T1" ref-type="table">Table 1</xref>].</p><table-wrap id="T1" position="float" orientation="portrait"><label>Table 1</label><caption><p>Histological changes and fractional clearance in various groups</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="2" colspan="1">Group</th><th valign="top" align="center" colspan="4" rowspan="1">Histology (number of rats)<hr/></th><th valign="top" align="center" rowspan="2" colspan="1"><italic toggle="yes">K</italic>
</th></tr><tr><th valign="top" align="center" rowspan="1" colspan="1">Normal</th><th valign="top" align="center" rowspan="1" colspan="1">Mild</th><th valign="top" align="center" rowspan="1" colspan="1">Moderate</th><th valign="top" align="center" rowspan="1" colspan="1">Severe</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">A</td><td valign="top" align="center" rowspan="1" colspan="1">4</td><td valign="top" align="center" rowspan="1" colspan="1">4</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">0.239±0.13</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">B</td><td valign="top" align="center" rowspan="1" colspan="1">-</td><td valign="top" align="center" rowspan="1" colspan="1">4</td><td valign="top" align="center" rowspan="1" colspan="1">1</td><td valign="top" align="center" rowspan="1" colspan="1">3</td><td valign="top" align="center" rowspan="1" colspan="1">0.079±0.009</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">C</td><td valign="top" align="center" rowspan="1" colspan="1">0</td><td valign="top" align="center" rowspan="1" colspan="1">4</td><td valign="top" align="center" rowspan="1" colspan="1">3</td><td valign="top" align="center" rowspan="1" colspan="1">1</td><td valign="top" align="center" rowspan="1" colspan="1">0.112±0.005</td></tr></tbody></table></table-wrap><fig id="C2" position="float" orientation="portrait"><label>Chart 2</label><caption><p>Fractional clearance of indocyanine green in various groups</p></caption><graphic xmlns:xlink="http://www.w3.org/1999/xlink" position="float" orientation="portrait" xlink:href="AJPS-15-5-g006.jpg"><?image-name AJPS-15-5-g006.jpg?><?image-size 18031?><?image-md5 b47c230f7a39dbb6534dcc89cf69cb7e?><?image-image-server-status NEVER_LOAD?><?image-original-height 236?><?image-original-width 274?><?image-scaled-height 236?><?image-scaled-width 274?><?image-cloudpmc-urn urn:cdn:blobs/153d/6419554/b47c230f7a39/AJPS-15-5-g006.jpg?><?thumb-name AJPS-15-5-g006.gif?><?thumb-size 3448?><?thumb-md5 f8210a7ce9abcdb17a9405abdea791cb?><?thumb-image-server-status NEVER_LOAD?><?thumb-scaled-height 86?><?thumb-scaled-width 100?><?thumb-cloudpmc-urn urn:cdn:blobs/153d/6419554/f8210a7ce9ab/AJPS-15-5-g006.gif?></graphic></fig><p>The mean serum alkaline phosphatase values were 99.3 ± 7.6 in Group A, 207 ± 133 in Group B, and 188 ± 72 in Group C [<xref rid="T2" ref-type="table">Table 2</xref>]. The serum bilirubin values were within normal limits in all rats.</p><table-wrap id="T2" position="float" orientation="portrait"><label>Table 2</label><caption><p>Liver function tests in the three groups</p></caption><table frame="hsides" rules="groups"><thead><tr><th valign="top" align="left" rowspan="1" colspan="1">Parameter</th><th valign="top" align="center" rowspan="1" colspan="1">Group A</th><th valign="top" align="center" rowspan="1" colspan="1">Group B</th><th valign="top" align="center" rowspan="1" colspan="1">Group C</th></tr></thead><tbody><tr><td valign="top" align="left" rowspan="1" colspan="1">Serum alkaline phosphatase</td><td valign="top" align="center" rowspan="1" colspan="1">99.25±7.6</td><td valign="top" align="center" rowspan="1" colspan="1">207.7±133.7</td><td valign="top" align="center" rowspan="1" colspan="1">188.5±72.48</td></tr><tr><td valign="top" align="left" rowspan="1" colspan="1">Serum bilirubin</td><td valign="top" align="center" rowspan="1" colspan="1">0.6</td><td valign="top" align="center" rowspan="1" colspan="1">0.59</td><td valign="top" align="center" rowspan="1" colspan="1">0.53</td></tr></tbody></table></table-wrap><p>K-values obtained in all the three groups were compared using Kruskal–Wallis test. Values obtained immediately after injection of dye/saline were comparable in all three groups and were found to be not significant (<italic toggle="yes">P</italic> &gt; 0.05).</p><p>At 1 min after injection, Groups B and C were compared with Group A, and changes were significant in both the groups (<italic toggle="yes">P</italic> &lt; 0.05).</p><p>At 3 min after injection, changes in Groups A and B and Groups A and C were highly significant (<italic toggle="yes">P</italic> &gt; 0.001). However, changes between Groups B and C were less significant (<italic toggle="yes">P</italic> &lt; 0.05).</p><p>At 5 min, changes between Groups A and B and Groups A and C were highly significant, whereas changes between Groups B and C were less significant (<italic toggle="yes">P</italic> &lt; 0.05).</p><p>At 10 min, changes between Groups A and B and Groups A and C were significant (<italic toggle="yes">P</italic> &lt; 0.01) and changes between Groups B and C were less significant (<italic toggle="yes">P</italic> &lt; 0.05).</p></sec><sec sec-type="discussion" id="sec1-4"><title>D<sc>ISCUSSION</sc></title><p>An experimental rat model of partial biliary obstruction as observed in the early stages of extrahepatic biliary atresia (EHBA) was created by injecting OK-432 directly into the bile ducts. OK-432 is a lyophilized mixture of Group A <italic toggle="yes">Streptococcus pyogenes</italic> of human origin. When injected locally into tissues, it evokes inflammation and infiltration by macrophages and neutrophils with the release of cytokines, macrophages, natural killer cells, and lymphocytes.[<xref rid="ref2" ref-type="bibr">2</xref>] Kuroiwa <italic toggle="yes">et al</italic>., in an experimental study, induced cholangitis by injecting OK-432 into hepatic duct of male guinea pigs and observed that acute inflammatory changes with edema and cellular infiltration in the proximal periportal area occurred as early as 24 h postinjection.[<xref rid="ref3" ref-type="bibr">3</xref>] The changes observed in the present study were maximum after 3 weeks of OK-432 injection, and changes decreased gradually, so mild-to-moderate changes were noted after 6 weeks of injection. Serum bilirubin estimation in all the groups was within normal limits, which suggests that this is not a reliable marker of liver injury. Serum alkaline phosphatase levels were raised significantly only in those rats in whom the moderate-to-severe degrees of histological changes were observed. For mild-to-moderate histological changes, this parameter was not a very reliable marker. Four rats in the control group had mild inflammatory changes in the porta, which can be attributed to trauma caused by needle puncture.</p><p>The liver performs a variety of functions in human body. No single test can adequately assess all these functions. Various biochemical and imaging studies including the hepatic scintigraphy and elastography are now available. However, their clinical efficacy has not been established yet.[<xref rid="ref4" ref-type="bibr">4</xref>] Hepatic clearance of ICG occurs by two major processes; by uptake across the sinusoidal plasma membrane with a high extraction ratio and by removal from the hepatocytes by cytoplasmic transport and exclusive biliary excretion (with neither intrahepatic conjugation nor enterohepatic circulation). After intravenous injection, ICG is rapidly and completely bound to plasma proteins, of which albumin is the principal carrier.[<xref rid="ref5" ref-type="bibr">5</xref>] It is not cleared by the kidney, and the peripheral uptake of the dye is negligible.[<xref rid="ref6" ref-type="bibr">6</xref><xref rid="ref7" ref-type="bibr">7</xref>] The studies have further shown that hepatic blood flow can be measured by calculating the rate of clearance in low dye concentration while the ICG clearance by hepatocytes at high dye concentrations represents a sensitive measure of hepatic cell function.[<xref rid="ref8" ref-type="bibr">8</xref><xref rid="ref9" ref-type="bibr">9</xref>] Hence, hepatic ICG clearance (both cytoplasmic transport and biliary excretion) has a close relationship with intrinsic liver cell function.[<xref rid="ref10" ref-type="bibr">10</xref><xref rid="ref11" ref-type="bibr">11</xref><xref rid="ref12" ref-type="bibr">12</xref>] However, as yet this has not been applied in clinical use as a liver function test. Shinohara et al, in a study showed that direct measurement of hepatic ICG clearance can be a useful method for comprehensive evaluation of liver function in clinical practice.[<xref rid="ref9" ref-type="bibr">9</xref>] In another study, Branch <italic toggle="yes">et al</italic>. showed that ICG provides qualitative assessment of two aspects of liver functions related to the uptake and the elimination of drugs.[<xref rid="ref13" ref-type="bibr">13</xref>] Leevy <italic toggle="yes">et al</italic>. studied ICG clearance and its alterations in patients with liver disease and correlated these findings with liver histology and observed that serial study of ICG clearance reflects improvement or deterioration in liver histopathology and was invaluable in following the course of both acute and chronic liver injury.[<xref rid="ref14" ref-type="bibr">14</xref>]</p><p>Sheng <italic toggle="yes">et al</italic>. investigated the correlation between the ICG clearance test and model for end-stage liver disease (MELD) score in patients with liver cirrhosis.[<xref rid="ref15" ref-type="bibr">15</xref>] The authors opined that the ICG clearance test and MELD score were good parameters for evaluating liver function. As ICG clearance per unit time (K) and retention of dye at 15 min after injection (R 15) have significant correlations with MELD score, especially the K value, it may be used to evaluate the liver function of patients with significant liver disease. In another study, Gupta <italic toggle="yes">et al</italic>. correlated the ICG clearance test with MELD score in 40 patients with cirrhosis Class A and B (based on CP score) patients and concluded that ICG R15 has a higher sensitivity and specificity than MELD score in assessing the prognosis of patients with cirrhosis of the liver.[<xref rid="ref16" ref-type="bibr">16</xref>]</p><p>Schneider studied the preoperative liver function in a group of Child–Pugh Class A patients using various tests and observed that no single test employed could adequately assess the liver function and the author suggested to complement these tests with 99mTc-galactosyl human serum albumin scintigraphy, which provides volumetric receptor data, as well as kinetic distribution curves.[<xref rid="ref17" ref-type="bibr">17</xref>]</p><p>In a study to evaluate the ICG clearance test in postoperative liver function in 19 patients with EHBA who had undergone hepatic portoenterostomy, Kubota <italic toggle="yes">et al</italic>. found that ICG-K value failed to go up into a normal range or declined afterward in cases, who developed ascending cholangitis in the early postoperative period but remained anicteric and these patients later on developed portal hypertension.[<xref rid="ref18" ref-type="bibr">18</xref>] The authors concluded that the estimation of ICG-K value was a reliable, comprehensive estimator of postoperative liver function. Hence, it was shown to be an important prognostic indicator as remaining of K-value below a normal range or declining below normal suggests clinical deterioration in the future. In the present study, ICG-K correlated well with different grades of liver injury as confirmed by histology. Variable grades of inflammatory changes were noted in the extrahepatic biliary ducts on histology. This confirms that OK-432 caused portal inflammation which caused changes in the liver as well. The grade of portal inflammation and sinusoidal infiltration with cells correlated well with the ICG-K value in different groups.</p></sec><sec sec-type="conclusions" id="sec1-5"><title>C<sc>ONCLUSION</sc></title><p>ICG clearance rate (ICG-K) is a reliable marker of liver cell function and can be utilized for evaluation of liver function in post-operative patients of extrahepatic biliary atresia.</p><sec id="sec2-1"><title>Financial support and sponsorship</title><p>Nil.</p></sec><sec id="sec2-2" sec-type="COI-statement"><title>Conflicts of interest</title><p>There are no conflicts of interest.</p></sec></sec></body><back><ref-list><title>R<sc>EFERENCES</sc></title><ref id="ref1"><label>1</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Paumgartner</surname><given-names>G</given-names></name><name name-style="western"><surname>Probst</surname><given-names>P</given-names></name><name name-style="western"><surname>Kraines</surname><given-names>R</given-names></name><name name-style="western"><surname>Leevy</surname><given-names>CM</given-names></name></person-group><article-title>Kinetics of indocyanin green removal from the blood</article-title><source>Ann N Y Acad Sci</source><year>1972</year><volume>170</volume><fpage>134</fpage><lpage>47</lpage></element-citation></ref><ref id="ref2"><label>2</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Ogita</surname><given-names>S</given-names></name><name name-style="western"><surname>Tsuto</surname><given-names>T</given-names></name><name name-style="western"><surname>Nakamura</surname><given-names>K</given-names></name><name name-style="western"><surname>Deguchi</surname><given-names>E</given-names></name><name name-style="western"><surname>Tokiwa</surname><given-names>K</given-names></name><name name-style="western"><surname>Iwai</surname><given-names>N</given-names></name><etal/></person-group><article-title>OK-432 therapy for lymphangioma in children: Why and how does it work?</article-title><source>J Pediatr Surg</source><year>1996</year><volume>31</volume><fpage>477</fpage><lpage>80</lpage><pub-id pub-id-type="pmid">8801295</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0022-3468(96)90478-9</pub-id></element-citation></ref><ref id="ref3"><label>3</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kuroiwa</surname><given-names>M</given-names></name><name name-style="western"><surname>Suzuki</surname><given-names>N</given-names></name><name name-style="western"><surname>Takuhasi</surname><given-names>A</given-names></name><name name-style="western"><surname>Ikeda</surname><given-names>H</given-names></name><name name-style="western"><surname>Murakami</surname><given-names>J</given-names></name><name name-style="western"><surname>Hatekeyama</surname><given-names>S</given-names></name><etal/></person-group><article-title>MRI of Cholangitis; Clinical Assessment &amp; Preliminary Report of OK-432 Induced Cholangitis Model</article-title><source>Presented in Sixth International Sendai Symposium on Biliary Atresia, May, 1996, Japan</source><year>1996</year></element-citation></ref><ref id="ref4"><label>4</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Mizuguchi</surname><given-names>T</given-names></name><name name-style="western"><surname>Kawamoto</surname><given-names>M</given-names></name><name name-style="western"><surname>Meguro</surname><given-names>M</given-names></name><name name-style="western"><surname>Hui</surname><given-names>TT</given-names></name><name name-style="western"><surname>Hirata</surname><given-names>K</given-names></name></person-group><article-title>Preoperative liver function assessments to estimate the prognosis and safety of liver resections</article-title><source>Surg Today</source><year>2014</year><volume>44</volume><fpage>1</fpage><lpage>0</lpage><pub-id pub-id-type="pmid">23474700</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1007/s00595-013-0534-4</pub-id></element-citation></ref><ref id="ref5"><label>5</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Keller</surname><given-names>E</given-names></name><name name-style="western"><surname>Ishihara</surname><given-names>H</given-names></name><name name-style="western"><surname>Nadler</surname><given-names>A</given-names></name><name name-style="western"><surname>Niederer</surname><given-names>P</given-names></name><name name-style="western"><surname>Seifert</surname><given-names>B</given-names></name><name name-style="western"><surname>Yonekawa</surname><given-names>Y</given-names></name><etal/></person-group><article-title>Evaluation of brain toxicity following near infrared light exposure after indocyanine green dye injection</article-title><source>J Neurosci Methods</source><year>2002</year><volume>117</volume><fpage>23</fpage><lpage>31</lpage><pub-id pub-id-type="pmid">12084561</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/s0165-0270(02)00044-4</pub-id></element-citation></ref><ref id="ref6"><label>6</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cohn</surname><given-names>JN</given-names></name><name name-style="western"><surname>Khatri</surname><given-names>IM</given-names></name><name name-style="western"><surname>Groszmann</surname><given-names>RJ</given-names></name><name name-style="western"><surname>Kotelanski</surname><given-names>B</given-names></name></person-group><article-title>Hepatic blood flow in alcoholic liver disease measured by an indicator dilution technic</article-title><source>Am J Med</source><year>1972</year><volume>53</volume><fpage>704</fpage><lpage>14</lpage><pub-id pub-id-type="pmid">4564238</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/0002-9343(72)90187-8</pub-id></element-citation></ref><ref id="ref7"><label>7</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Leevy</surname><given-names>CM</given-names></name><name name-style="western"><surname>Mendenhall</surname><given-names>CL</given-names></name><name name-style="western"><surname>Lesko</surname><given-names>W</given-names></name><name name-style="western"><surname>Howard</surname><given-names>MM</given-names></name></person-group><article-title>Estimation of hepatic blood flow with indocyanine green</article-title><source>J Clin Invest</source><year>1962</year><volume>41</volume><fpage>1169</fpage><lpage>79</lpage><pub-id pub-id-type="pmid">14463639</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1172/JCI104570</pub-id><pub-id pub-id-type="pmcid">PMC291025</pub-id></element-citation></ref><ref id="ref8"><label>8</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Cherriek</surname><given-names>GR</given-names></name><name name-style="western"><surname>Stein</surname><given-names>SW</given-names></name><name name-style="western"><surname>Leevy</surname><given-names>CM</given-names></name><name name-style="western"><surname>Davidson</surname><given-names>CS</given-names></name></person-group><article-title>Indocyanin Green: Observation on its physical properties, plasma decay and hepatic extraction</article-title><source>J Clin Invest</source><year>1960</year><volume>39</volume><fpage>591</fpage><lpage>600</lpage><pub-id pub-id-type="doi" assigning-authority="pmc">10.1172/JCI104072</pub-id><pub-id pub-id-type="pmcid">PMC293343</pub-id><pub-id pub-id-type="pmid">13809697</pub-id></element-citation></ref><ref id="ref9"><label>9</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Shinohara</surname><given-names>H</given-names></name><name name-style="western"><surname>Tanaka</surname><given-names>A</given-names></name><name name-style="western"><surname>Kitai</surname><given-names>T</given-names></name><name name-style="western"><surname>Yanabu</surname><given-names>N</given-names></name><name name-style="western"><surname>Inomoto</surname><given-names>T</given-names></name><name name-style="western"><surname>Satoh</surname><given-names>S</given-names></name><etal/></person-group><article-title>Direct measurement of hepatic indocyanine green clearance with near-infrared spectroscopy: Separate evaluation of uptake and removal</article-title><source>Hepatology</source><year>1996</year><volume>23</volume><fpage>137</fpage><lpage>44</lpage><pub-id pub-id-type="pmid">8550033</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1053/jhep.1996.v23.pm0008550033</pub-id></element-citation></ref><ref id="ref10"><label>10</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Zimniak</surname><given-names>P</given-names></name><name name-style="western"><surname>Awasthi</surname><given-names>YC</given-names></name></person-group><article-title>ATP-dependent transport systems for organic anions</article-title><source>Hepatology</source><year>1993</year><volume>17</volume><fpage>330</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">8428732</pub-id></element-citation></ref><ref id="ref11"><label>11</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sathirakul</surname><given-names>K</given-names></name><name name-style="western"><surname>Suzuki</surname><given-names>H</given-names></name><name name-style="western"><surname>Yasuda</surname><given-names>K</given-names></name><name name-style="western"><surname>Hanano</surname><given-names>M</given-names></name><name name-style="western"><surname>Tagaya</surname><given-names>O</given-names></name><name name-style="western"><surname>Horie</surname><given-names>T</given-names></name><etal/></person-group><article-title>Kinetic analysis of hepatobiliary transport of organic anions in Eisai hyperbilirubinemic mutant rats</article-title><source>J Pharmacol Exp Ther</source><year>1993</year><volume>265</volume><fpage>1301</fpage><lpage>12</lpage><pub-id pub-id-type="pmid">8510010</pub-id></element-citation></ref><ref id="ref12"><label>12</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sathirakul</surname><given-names>K</given-names></name><name name-style="western"><surname>Suzuki</surname><given-names>H</given-names></name><name name-style="western"><surname>Yamada</surname><given-names>T</given-names></name><name name-style="western"><surname>Hanano</surname><given-names>M</given-names></name><name name-style="western"><surname>Sugiyama</surname><given-names>Y</given-names></name></person-group><article-title>Multiple transport systems for organic anions across the bile canalicular membrane</article-title><source>J Pharmacol Exp Ther</source><year>1994</year><volume>268</volume><fpage>65</fpage><lpage>73</lpage><pub-id pub-id-type="pmid">8301595</pub-id></element-citation></ref><ref id="ref13"><label>13</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Branch</surname><given-names>RA</given-names></name><name name-style="western"><surname>James</surname><given-names>JA</given-names></name><name name-style="western"><surname>Read</surname><given-names>AE</given-names></name></person-group><article-title>The clearance of antipyrine and indocyanine green in normal subjects and in patients with chronic lever disease</article-title><source>Clin Pharmacol Ther</source><year>1976</year><volume>20</volume><fpage>81</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">1277728</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1002/cpt197620181</pub-id></element-citation></ref><ref id="ref14"><label>14</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Leevy</surname><given-names>CM</given-names></name><name name-style="western"><surname>Smith</surname><given-names>F</given-names></name><name name-style="western"><surname>Longueville</surname><given-names>J</given-names></name><name name-style="western"><surname>Paumgartner</surname><given-names>G</given-names></name><name name-style="western"><surname>Howard</surname><given-names>MM</given-names></name></person-group><article-title>Indocyanine green clearance as a test for hepatic function. Evaluation by dichromatic ear densitometry</article-title><source>JAMA</source><year>1967</year><volume>200</volume><fpage>236</fpage><lpage>40</lpage><pub-id pub-id-type="pmid">6071462</pub-id></element-citation></ref><ref id="ref15"><label>15</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Sheng</surname><given-names>QS</given-names></name><name name-style="western"><surname>Lang</surname><given-names>R</given-names></name><name name-style="western"><surname>He</surname><given-names>Q</given-names></name><name name-style="western"><surname>Yang</surname><given-names>YJ</given-names></name><name name-style="western"><surname>Zhao</surname><given-names>DF</given-names></name><name name-style="western"><surname>Chen</surname><given-names>DZ</given-names></name><etal/></person-group><article-title>Indocyanine green clearance test and model for end-stage liver disease score of patients with liver cirrhosis</article-title><source>Hepatobiliary Pancreat Dis Int</source><year>2009</year><volume>8</volume><fpage>46</fpage><lpage>9</lpage><pub-id pub-id-type="pmid">19208514</pub-id></element-citation></ref><ref id="ref16"><label>16</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Gupta</surname><given-names>S</given-names></name><name name-style="western"><surname>Chawla</surname><given-names>Y</given-names></name><name name-style="western"><surname>Kaur</surname><given-names>J</given-names></name><name name-style="western"><surname>Saxena</surname><given-names>R</given-names></name><name name-style="western"><surname>Duseja</surname><given-names>A</given-names></name><name name-style="western"><surname>Dhiman</surname><given-names>RK</given-names></name><etal/></person-group><article-title>Indocyanine green clearance test (using spectrophotometry) and its correlation with model for end stage liver disease (MELD) score in Indian patients with cirrhosis of liver</article-title><source>Trop Gastroenterol</source><year>2012</year><volume>33</volume><fpage>129</fpage><lpage>34</lpage><pub-id pub-id-type="pmid">23025060</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.7869/tg.2012.30</pub-id></element-citation></ref><ref id="ref17"><label>17</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Schneider</surname><given-names>PD</given-names></name></person-group><article-title>Preoperative assessment of liver function</article-title><source>Surg Clin North Am</source><year>2004</year><volume>84</volume><fpage>355</fpage><lpage>73</lpage><pub-id pub-id-type="pmid">15062650</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1016/S0039-6109(03)00224-X</pub-id></element-citation></ref><ref id="ref18"><label>18</label><element-citation publication-type="journal"><person-group person-group-type="author"><name name-style="western"><surname>Kubota</surname><given-names>A</given-names></name><name name-style="western"><surname>Okada</surname><given-names>A</given-names></name><name name-style="western"><surname>Fukui</surname><given-names>Y</given-names></name><name name-style="western"><surname>Kawahara</surname><given-names>H</given-names></name><name name-style="western"><surname>Imura</surname><given-names>K</given-names></name><name name-style="western"><surname>Kamata</surname><given-names>S</given-names></name><etal/></person-group><article-title>Indocyanine green test is a reliable indicator of postoperative liver function in biliary atresia</article-title><source>J Pediatr Gastroenterol Nutr</source><year>1993</year><volume>16</volume><fpage>61</fpage><lpage>5</lpage><pub-id pub-id-type="pmid">8433242</pub-id><pub-id pub-id-type="doi" assigning-authority="pmc">10.1097/00005176-199301000-00012</pub-id></element-citation></ref></ref-list></back></article>